Economy
Agreement Inked To Establish Vaccines Factory In Khazaen City Worth RO20M
Khazaen Economic City signed an agreement with Opal For Biopharmaceuticals and Business Company to establish a factory for the production of biological human vaccines to the tune of RO20mn.
The first phase of the project will be set up on a total area of 37,000 square meters.

The agreement was signed by Eng. Salim Al Thuhli, CEO of Khazaen and Sa’ad Moosa Al Junaibi, Chairman of the Board of Directors of Opal For Biopharmaceuticals and Business Company.
Al Thuhli said that this project will be the first vaccines factory in Khazaen Economic City and it targets local and international markets. The agreement, Al Thuhli added, comes as part of Khazaen’s efforts in attracting local and international investments.
-
News2 months agoINVESTIGATION: Why Nokia Could Matter More in the Quantum Age Than It Ever Did in Mobile
-
News2 months agoINVESTIGATION: Is AI in a Bubble? Inside the Trillion-Dollar Question Reshaping Global Markets
-
News2 months agoThales & Ankaa to Deliver Multi-Mission Air Traffic Surveillance Radars for Oman, Capable of Supporting Civil & Military Operations
-
Economy2 months agoWhat Higher Oil Prices Mean for Oman’s Economy in 2026
-
Economy2 months agoOMIFCO Successfully Completes Bookbuilding & Sets Final IPO Offer Price
-
Business2 months agoOman India Fertiliser Company Lists on Muscat Stock Exchange
-
Banking & Finance1 month agoBank Muscat posts net profit of RO137.49 million in H1 2026
-
Insurance2 months agoLEADERSPEAK: Dhofar Insurance CEO Sunil Kohli on Oman’s Insurance Sector, Reinsurance & Market Outlook
